| abstract |
The present invention relates to a method for treating cancer, for instance brain tumors, in a subject by inhibiting tenascin W by administering to said subject a therapeutically effective amount of a modulator or said tenascin, for example a specific antibody or a siRNA. The present invention also encompasses methods of diagnosing cancer by measuring levels of tenascin-W, as well as method of targeted therapy using anti-tenascin-W antibodies conjugated to therapeutic agents. |